LC
INFI

Lindbrook Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Lindbrook Capital’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,000
Closed -$36K – 2038
2021
Q2 		$36K Buy
+12,000
New +$38K 0.01% 581

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lindbrook Capital's INFI Position: Q3 2021 in Review

Lindbrook Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2021, closing a stake of 12,000 shares — an estimated $36K sold.

Lindbrook Capital first reported a position in INFI in Q2 2021 and held it in 1 quarter. The position peaked at $36K in Q2 2021. 107 funds tracked by Wall St. Rank hold INFI as of Q3 2021.

  • Lindbrook Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Lindbrook Capital sold 12,000 Infinity Pharmaceuticals, Inc. shares in Q3 2021, an estimated $36K.
  • Lindbrook Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Lindbrook Capital's Infinity Pharmaceuticals, Inc. position peaked at $36K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2021.

Based on Lindbrook Capital's 13F filing for Q3 2021, filed 5 Nov 2021.